Back to Dashboard
UTH

United Therapeutics Corp Del

USA Filing: 2026-06-30
34/100
Smart-money confidence
Below average interest

No standout activity across the feeds we track.

Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →

9
hedge funds
hold it · 1 new, 2 added, 4 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Who's behind the signal
Every informed buyer we can see on UTH, across all three feeds.
Hedge funds · 9
Point72 (Steve Cohen) Increased +35%
Renaissance Technologies Decreased −4%
Baillie Gifford & Co Decreased −19%
+3 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. UNITED THERAPEUTICS CORP DEL isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
1
New positions
2
Increasing
4
Decreasing
2
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset Pinch to zoom · drag sideways to move through time
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to UNITED THERAPEUTICS CORP DEL
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell UNITED THERAPEUTICS CORP DEL or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订 · 隐私